In Vitro Diagnostic Substances, Reagents, Test Kits And Sets

Code 6550
Child
Spend Category Level 1
Medical
Spend Category Level 2
Medical Equipment and Accessories and Supplies
Popular Federal Contract Opportunities
Not listed
Popular Federal Contract Awards
Not listed

Product Service Code (PSC) 6550, designated as "In Vitro Diagnostic Substances, Reagents, Test Kits And Sets," encompasses a broad range of medical diagnostic technologies and laboratory testing supplies. These products are critical for clinical diagnostics, medical research, and healthcare testing, covering molecular, immunological, microbial, and genetic testing platforms. The category includes reagents, test kits, calibration materials, controls, and consumables designed for use with specialized medical analyzers and diagnostic equipment across various healthcare and research settings.

Federal Contract Awards in this PSC category predominantly feature firm-fixed-price contracts with the Department of Veterans Affairs, Department of Health and Human Services, and military medical commands. Contract values typically range from $10,000 to $2.5 million, with performance periods spanning one to five years. Frequent awardees include Roche Diagnostics, Cepheid, Abbott Laboratories, Beckman Coulter, and Sysmex America. Most awards are unrestricted, though some utilize small business set-asides, particularly Service-Disabled Veteran-Owned Small Business designations. Performance locations are primarily federal medical facilities across the United States, with significant concentrations in California, Texas, and the Northeast.

Recent federal contract opportunities in PSC 6550 focus on acquiring comprehensive diagnostic testing systems and associated supplies for various medical laboratories. Solicitations include requests for molecular diagnostic platforms, immunoassay reagents, toxicology testing supplies, and specialized pathogen detection technologies. Agencies like the Department of Veterans Affairs, National Institutes of Health, Indian Health Service, and Defense Health Agency are actively seeking advanced diagnostic solutions. Opportunities cover testing for infectious diseases, genetic markers, blood banking, cancer screening, and workplace drug testing, with most performance locations situated at military medical centers, VA healthcare systems, and research institutions across the continental United States.

Generated 1/19/25, 1:22 AM